Immunogenicity and Safety of Vaccine Against Tetanus and Diphtheria.

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
A single blind, randomized, comparative, multicentre clinical trial of the immunogenicity and safety of booster immunization with bivalent vaccine against tetanus and diphtheria CLODIVAC (IBSS BIOMED S.A.) and Td-Impfstoff Mérieux (Sanofi Pasteur) in healthy adults.
Epistemonikos ID: 122b7a1ac942ace3614c1b02bc65c9b85215b48f
First added on: May 13, 2024